Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Medicina (Kaunas) ; 59(1)2023 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-36676765

RESUMO

Diabetes mellitus (DM) has a growing prevalence worldwide, even in developing countries. Many antidiabetic agents are used to improve glycemic control; however, in cases of an insufficient outcome, insulin is administered. Yet, the timing of proper insulin administration is still a subject of intense research. To date, there have been no recommendations or guidelines for the use of continuous subcutaneous insulin infusion (CSII) in Type 2 Diabetes Mellitus (T2DM). In the present study, we have performed a meta-analysis to evaluate the use of CSII in patients with T2DM. An extensive literature search was conducted through the electronic databases Pubmed, Clinicaltrials.gov, and Cochrane Central Register of Controlled Trials (CENTRAL) from October 2019-May 2022, for interventional studies related to T2DMI and CSII versus multiple daily injections (MDI). We included articles published in the English language only, yielding a total of thirteen studies. We found better outcomes in patients receiving CSII, in regard to glycated hemoglobin (HbA1c) and total insulin dose. In contrast, fasting plasma glucose and body weight did not show statistically significant differences between the two groups. Our analyses showed that CSII could be beneficial in patients with T2DM in order to achieve their glucose targets.


Assuntos
Diabetes Mellitus Tipo 1 , Diabetes Mellitus Tipo 2 , Humanos , Diabetes Mellitus Tipo 2/tratamento farmacológico , Injeções Subcutâneas , Sistemas de Infusão de Insulina , Insulina/uso terapêutico , Hipoglicemiantes/efeitos adversos , Glicemia
4.
J Clin Endocrinol Metab ; 105(7)2020 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-32170323

RESUMO

CONTEXT: Patients with adrenal insufficiency require increased hydrocortisone cover during major stress to avoid a life-threatening adrenal crisis. However, current treatment recommendations are not evidence-based. OBJECTIVE: To identify the most appropriate mode of hydrocortisone delivery in patients with adrenal insufficiency who are exposed to major stress. DESIGN AND PARTICIPANTS: Cross-sectional study: 122 unstressed healthy subjects and 288 subjects exposed to different stressors (major trauma [N = 83], sepsis [N = 100], and combat stress [N = 105]). Longitudinal study: 22 patients with preserved adrenal function undergoing elective surgery. Pharmacokinetic study: 10 patients with primary adrenal insufficiency undergoing administration of 200 mg hydrocortisone over 24 hours in 4 different delivery modes (continuous intravenous infusion; 6-hourly oral, intramuscular or intravenous bolus administration). MAIN OUTCOME MEASURE: We measured total serum cortisol and cortisone, free serum cortisol, and urinary glucocorticoid metabolite excretion by mass spectrometry. Linear pharmacokinetic modeling was used to determine the most appropriate mode and dose of hydrocortisone administration in patients with adrenal insufficiency exposed to major stress. RESULTS: Serum cortisol was increased in all stress conditions, with the highest values observed in surgery and sepsis. Continuous intravenous hydrocortisone was the only administration mode persistently achieving median cortisol concentrations in the range observed during major stress. Linear pharmacokinetic modeling identified continuous intravenous infusion of 200 mg hydrocortisone over 24 hours, preceded by an initial bolus of 50-100 mg hydrocortisone, as best suited for maintaining cortisol concentrations in the required range. CONCLUSIONS: Continuous intravenous hydrocortisone infusion should be favored over intermittent bolus administration in the prevention and treatment of adrenal crisis during major stress.


Assuntos
Insuficiência Adrenal/tratamento farmacológico , Glucocorticoides/administração & dosagem , Hidrocortisona/administração & dosagem , Sepse/complicações , Estresse Fisiológico/fisiologia , Estresse Psicológico/complicações , Administração Oral , Adolescente , Insuficiência Adrenal/sangue , Insuficiência Adrenal/complicações , Insuficiência Adrenal/fisiopatologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Cortisona/sangue , Estudos Transversais , Esquema de Medicação , Feminino , Glucocorticoides/uso terapêutico , Humanos , Hidrocortisona/sangue , Hidrocortisona/uso terapêutico , Infusões Intravenosas , Masculino , Espectrometria de Massas , Pessoa de Meia-Idade , Sepse/sangue , Estresse Psicológico/sangue , Resultado do Tratamento , Adulto Jovem
5.
BMC Fam Pract ; 12: 136, 2011 Dec 06.
Artigo em Inglês | MEDLINE | ID: mdl-22145678

RESUMO

BACKGROUND: Research has indicated that general practitioners (GPs) have good clinical judgment in regards to diagnosing and managing herpes zoster (HZ) within clinical practice in a country with limited resources for primary care and general practice. The objective of the current study was to assess the burden of HZ and post herpetic neuralgia (PHN) within rural general practices in Crete, Greece. METHODS: The current study took place within a rural setting in Crete, Greece during the period of November 2007 to November 2009 within the catchment area in which the Cretan Rural Practice-based Research Network is operating. In total 19 GP's from 14 health care units in rural Crete were invited to participate, covering a total turnover patient population of approximately 25, 000 subjects. For the purpose of this study an electronic record database was constructed and used as the main tool for monitoring HZ and PHN incidence. Stress related data was also collected with the use of the Short Anxiety Screening Test (SAST). RESULTS: The crude incidence rate of HZ was 1.4/1000 patients/year throughout the entire network of health centers and satellite practices, while among satellite practices alone it was calculated at 1.3/1000 patients/year. Additionally, the standardised incidence density within satellite practices was calculated at 1.6/1000 patients/year. In regards to the stress associated with HZ and PHN, the latter were found to have lower levels of anxiety, as assessed through the SAST score (17.4 ± 3.9 vs. 21.1 ± 5.7; p = 0.029). CONCLUSIONS: The implementation of an electronic surveillance system was feasible so as to measure the burden of HZ and PHN within the rural general practice setting in Crete.


Assuntos
Efeitos Psicossociais da Doença , Medicina de Família e Comunidade/normas , Herpes Zoster/economia , Neuralgia Pós-Herpética/economia , Atenção Primária à Saúde/economia , Garantia da Qualidade dos Cuidados de Saúde/métodos , Serviços de Saúde Rural/economia , Adulto , Idoso , Idoso de 80 Anos ou mais , Área Programática de Saúde/estatística & dados numéricos , Redes Comunitárias/estatística & dados numéricos , Registros Eletrônicos de Saúde/estatística & dados numéricos , Feminino , Grécia/epidemiologia , Pesquisa sobre Serviços de Saúde , Herpes Zoster/diagnóstico , Herpes Zoster/epidemiologia , Humanos , Incidência , Masculino , Estado Civil , Pessoa de Meia-Idade , Neuralgia Pós-Herpética/diagnóstico , Neuralgia Pós-Herpética/epidemiologia , Atenção Primária à Saúde/estatística & dados numéricos , Psicometria/métodos , Serviços de Saúde Rural/normas , Serviços de Saúde Rural/estatística & dados numéricos , Vigilância de Evento Sentinela , Classe Social , Estresse Psicológico/classificação , Estresse Psicológico/diagnóstico
6.
Am J Kidney Dis ; 49(1): 91-8, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17185149

RESUMO

BACKGROUND: Little information on the management and long-term follow-up of patients with biallelic mutations in the chloride channel gene CLCNKB is available. METHODS: Long-term follow-up was evaluated from 5.0 to 24 years (median, 14 years) after diagnosis in 13 patients with homozygous (n = 10) or compound heterozygous (n = 3) mutations. RESULTS: Medical treatment at last follow-up control included supplementation with potassium in 12 patients and sodium in 2 patients and medical treatment with indomethacin in 9 patients. At the end of follow-up, body height was 2.0 standard deviation score or less in 6 patients; 2 of these patients had growth hormone deficiency. Body weight (

Assuntos
Síndrome de Bartter/genética , Canais de Cloreto/genética , Mutação , Adolescente , Adulto , Alelos , Síndrome de Bartter/tratamento farmacológico , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Masculino , Fatores de Tempo
7.
J Clin Endocrinol Metab ; 89(2): 574-80, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14764764

RESUMO

Tumors metastatic to the pituitary gland are an unusual complication of systemic cancer typically seen in elderly patients with diffuse malignant disease. Breast and lung are the commonest sites of the primary tumor, whereas diabetes insipidus is the most frequent symptom at presentation. Their rarity and usually indolent course, as well as the lack of specific clinical and radiological features, impede their differentiation from other more common sellar area lesions, particularly when history of malignancy is absent. Management of these patients may also be very difficult because the prognosis depends on the course of the primary neoplasm. A 68-yr-old man, with no history of malignancy, presented with recent onset of hypopituitarism, mild diabetes insipidus, headaches, left oculomotor nerve palsy, and progressive bilateral deterioration of visual acuity and visual fields. Magnetic resonance imaging revealed a large sellar mass compressing the optic chiasm and invading the left cavernous sinus, whereas a prolactin elevation at 438.6 ng/ml (19.73 nmol/liter) was noted. Decompression of the sellar region was attempted, and pathology disclosed a metastatic hepatocellular carcinoma. On postoperative investigation, primary liver tumor was identified and confirmed by biopsy. The patient improved transiently but died 3 months after diagnosis because of deterioration of the liver disease. The relevant literature is reviewed in light of this unusual case, illustrating the problems in the diagnosis and management of patients with metastasis to the pituitary.


Assuntos
Carcinoma Hepatocelular/sangue , Carcinoma Hepatocelular/secundário , Neoplasias Hepáticas/patologia , Neoplasias Hipofisárias/sangue , Neoplasias Hipofisárias/secundário , Prolactina/sangue , Idoso , Carcinoma Hepatocelular/diagnóstico , Carcinoma Hepatocelular/cirurgia , Diagnóstico Diferencial , Humanos , Imageamento por Ressonância Magnética , Masculino , Invasividade Neoplásica , Neoplasias Hipofisárias/diagnóstico , Neoplasias Hipofisárias/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...